ClinicalTrials.gg

Program

galvokimig

Also written as “Galvokimig” and “UCB9741”.

Its studies are mostly in Dermatitis, Atopic · Bronchiectasis · Bronchitis, Chronic, led by UCB.

Furthest: phase 2, since Nov 19, 20205 company-led studies, 3 open or runningNext primary completion: May 17, 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
UCB53 open or runningphase 2since Nov 19, 2020Nov 19, 2020May 17, 2027phase 2 · NCT07277660

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Nov 19, 2020First study: phase 2 study in Dermatitis, AtopicFirst studyNCT04643457 · 107 enrolled · Bulgaria, Germany, Netherlands and more
  2. Mar 11, 2024Phase 1 study in Healthy ParticipantsNCT06315335 · 40 enrolled · United States
  3. Dec 2, 2025Phase 2 study in Dermatitis, AtopicNCT07277660 · 165 enrolled · United States, Bulgaria, Canada and more
  4. Jul 17, 20262 phase 2 studiesNCT07720375, NCT07725939

Ahead

  1. May 17, 2027Primary completion: phase 2 study in Dermatitis, AtopicNCT07277660
  2. Feb 28, 2029Primary completion: phase 2 study in Non-cystic Fibrosis BronchiectasisNCT07720375
  3. Jun 29, 2029Primary completion: phase 2 study in Pulmonary Disease, Chronic ObstructiveNCT07725939

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07725939Pulmonary Disease, Chronic Obstructive · United States, China2RecruitingJun 29, 2029402
NCT07720375Non-cystic Fibrosis Bronchiectasis · United States2RecruitingFeb 28, 2029300
NCT07277660Dermatitis, Atopic · United States, Bulgaria, Canada and more2Active, not recruitingMay 17, 2027165
NCT06315335Healthy Participants · United States1CompletedJan 1, 202540
NCT04643457Dermatitis, Atopic · Bulgaria, Germany, Netherlands and more2CompletedApr 23, 2024107

How it is read

Names in the registry

  • “Galvokimig”, 3 entries
  • “UCB9741”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.